The White House’s Approach to Frontier AI Might Be Worse Than an “FDA For AI”

The White House is increasingly directing how companies provide access to frontier AI models, effectively shifting regulatory control away from private tech firms. This approach creates a centralized oversight structure that dictates development standards and deployment paths for the most powerful systems. Critics argue that this intervention could stifle innovation and exceed the authority typically associated with formal regulatory agencies.